Ophthalmic Goods · CIK 1860742
Bausch & Lomb protects and enhances sight with a comprehensive portfolio of eye health products and devices
Comparable business profile · signals at a glance
In the 90 days to Mar 6, 2026: 9 insiders bought $1.2M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 6, 2026 | Saunders Brent LCEO and Chairman of the Board | Buy | 14,700 | $17.14 | $252K |
| Mar 6, 2026 | Bailey A Robert DEVP & Chief Legal Officer | Buy | 14,600 | $17.15 | $250K |
| Mar 6, 2026 | Eldessouky SamEVP and CFO | Buy | 4,000 | $17.13 | $69K |
| Mar 3, 2026 | Ross Thomas W. Sr.Director | Buy | 4,500 | $17.68 | $80K |
| Mar 2, 2026 | Alfonso EduardoDirector | Buy | 4,300 | $17.90 | $77K |
| Feb 27, 2026 | Von Eschenbach Andrew C.Director | Buy | 4,364 | $18.31 | $80K |
| Feb 23, 2026 | Collis Steven HDirector | Buy | 15,000 | $17.81 | $267K |
| Feb 20, 2026 | Robertson Russel CDirector | Buy | 4,400 | $17.90 | $79K |
| Feb 19, 2026 | Ling KarenDirector | Buy | 4,000 | $17.74 | $71K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.